Phase III Clinical Trial for Immunogenecity and Safety of a New Recombinant Hepatitis B Virus Vaccine (HG-II) in the Newborn-Reference-Cited by-同舟云学术

Phase III Clinical Trial for Immunogenecity and Safety of a New Recombinant Hepatitis B Virus Vaccine (HG-II) in the Newborn

Published:1996 Issue:2 Volume:4 Page:197
ISSN:1225-5467
Container-title:Journal of Korean Society for Clinical Pharmacology and Therapeutics
language:ko
Short-container-title:J Korean Soc Clin Pharmacol Ther

Author:

Cho Yun-Kyong¹,Jung Yang-Suk¹,Yi Gye-Woo¹,Kim Yoon-Ok¹,Choi Myoung-Bum¹,Shin Sun-Kyung¹,Park Chan-Hoo¹,Woo Hyang-Ok¹,Youn Hee-Shang¹,Maeng Kook-Young²

Affiliation:

1. Department of Pediatrics, Gyeongsang National University College of Medicine, Chinju, Republic of Korea.

2. Department of Clinical Pathology, Gyeongsang National University College of Medicine, Chinju, Republic of Korea.

Publisher

Korean Society for Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical)

Link

https://www.tcpharm.org/pdf/10.12793/jkscpt.1996.4.2.197

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China;Pediatric Infectious Disease Journal;2017-01

2. The Safety and Immunogenicity of Two Hepatitis B Vaccine Formulations (Thiomersal-free and Thiomersal-containing) in Healthy Vietnamese Infants;Pediatric Infectious Disease Journal;2015-01

3. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene®) in healthy adults;Vaccine;2006-06

4. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years;Vaccine;2002-03